Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal CancerRecruiting
NCT06225011Phase 1Updated Aug 20, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Colorectal Adenocarcinoma
United States
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic ExposureNot Yet Recruiting
NCT07775495N/AUpdated Aug 20, 2026
Sponsor: Ecotera Health LLC
Healthy Adult Participants
United States
Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin LymphomaRecruiting
NCT06745076Phase 2Updated Aug 20, 2026
Sponsor: University of Washington
Advanced Hodgkin Lymphoma · Classic Hodgkin Lymphoma · Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 · Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
United States
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF TherapyActive Not Recruiting
NCT05889182Phase 3Updated Aug 20, 2026
Sponsor: AbbVie
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +32 more
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)Recruiting
NCT06103864Phase 3Updated Aug 20, 2026
Sponsor: AstraZeneca
Breast Cancer
United States, Argentina, Australia, Brazil, Canada +19 more
Parental Decision-Making for Children With Relapsed NeuroblastomaActive Not Recruiting
NCT02282735N/AUpdated Aug 20, 2026
Sponsor: Dana-Farber Cancer Institute
Relapsed Neuroblastoma
United States
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine TumorsRecruiting
NCT04665739Phase 2Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Lung Neuroendocrine Tumor · Functioning Lung Neuroendocrine Tumor · Locally Advanced Lung Neuroendocrine Neoplasm · Lung Neuroendocrine Neoplasm
United States
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeRecruiting
NCT07582172Phase 2Updated Aug 20, 2026
Sponsor: City of Hope Medical Center
Acute Myeloid Leukemia With Complex Karyotype · Myelodysplastic Chronic Myelomonocytic Leukemia · Myelodysplastic Syndrome · Recurrent Acute Myeloid Leukemia
United States
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)Recruiting
NCT06783309Phase 1, Phase 2Updated Aug 20, 2026
Sponsor: COUR Pharmaceutical Development Company, Inc.
Type 1 Diabetes Mellitus · T1D · T1DM · T1DM - Type 1 Diabetes Mellitus
United States
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic EsophagitisRecruiting
NCT07112378Phase 3Updated Aug 20, 2026
Sponsor: Regeneron Pharmaceuticals
Eosinophilic Esophagitis (EoE)
United States
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube CancerActive Not Recruiting
NCT01081262Phase 3Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Borderline Ovarian Mucinous Tumor · Ovarian Mucinous Cystadenocarcinoma · Recurrent Fallopian Tube Carcinoma · Recurrent Ovarian Carcinoma
United States
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRecruiting
NCT06001788Phase 1Updated Aug 20, 2026
Sponsor: Kura Oncology, Inc.
AML · AML With Mutated NPM1 · Hematologic Malignancy · KMT2Ar
United States, Italy, Spain
Vorinostat and Temozolomide in Treating Patients With Malignant GliomasActive Not Recruiting
NCT00268385Phase 1Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Adult Anaplastic Astrocytoma · Adult Anaplastic Oligodendroglioma · Adult Giant Cell Glioblastoma · Adult Glioblastoma
United States
Prospective Natural History Study of POLG DiseaseNot Yet Recruiting
NCT07775872N/AUpdated Aug 20, 2026
Sponsor: The POLG Foundation
PolG, Primary Mitochondrial Myopathy
United States
Caring for Dementia Caregivers in Ethnic Immigrant CommunitiesRecruiting
NCT07550075NAUpdated Aug 20, 2026
Sponsor: University of Southern California
No Disease or Condition is Being Studied · Stress (Psychology)
United States
AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic CancerRecruiting
NCT07619313Phase 1Updated Aug 20, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Borderline Resectable Pancreatic Ductal Adenocarcinoma · Locally Advanced Cholangiocarcinoma · Locally Advanced Pancreatic Adenocarcinoma · Metastatic Cholangiocarcinoma
United States
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney DiseaseActive Not Recruiting
NCT06926660Phase 2Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Chronic Kidney Disease
United States, Argentina, Australia, Belgium, Brazil +19 more
Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney CancerTerminated
NCT04473781Phase 1Updated Aug 20, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Stage I Renal Cell Cancer · Stage II Renal Cell Cancer
United States
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)Recruiting
NCT06064097Phase 2Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Stage II Nasopharyngeal Carcinoma AJCC v8 · Stage III Nasopharyngeal Carcinoma AJCC v8 · Stage IV Nasopharyngeal Carcinoma AJCC v8
United States, Australia, Canada, New Zealand, Puerto Rico
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseRecruiting
NCT07064473Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Diabetes Mellitus, Type 2 · Hypertension · Cardiovascular Diseases
United States, Argentina, Australia, Austria, Belgium +46 more
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus ErythematosusRecruiting
NCT07430306Phase 3Updated Aug 20, 2026
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
United States, Canada, France, Germany, Italy +4 more
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)Recruiting
NCT07107945Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Chronic Kidney Disease
United States, Argentina, Australia, Belgium, Canada +13 more
Testing ALERT With GTO in Middle SchoolsActive Not Recruiting
NCT05219422NAUpdated Aug 20, 2026
Sponsor: RAND
Substance Abuse
United States
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)Recruiting
NCT06952699Phase 2Updated Aug 20, 2026
Sponsor: Takeda
Narcolepsy Type 2
United States, China, France, Italy, Japan +2 more
Stress Management ProgramActive Not Recruiting
NCT06526585NAUpdated Aug 20, 2026
Sponsor: Stanford University
Stress · Anxiety
United States

Previous page Next page